sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large...
28
Transcript of sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large...
![Page 1: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/1.jpg)
![Page 2: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/2.jpg)
![Page 3: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/3.jpg)
![Page 4: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/4.jpg)
![Page 5: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/5.jpg)
![Page 6: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/6.jpg)
![Page 7: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/7.jpg)
![Page 8: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/8.jpg)
![Page 9: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/9.jpg)
![Page 10: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/10.jpg)
![Page 11: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/11.jpg)
![Page 12: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/12.jpg)
![Page 13: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/13.jpg)
![Page 14: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/14.jpg)
![Page 15: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/15.jpg)
![Page 16: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/16.jpg)
![Page 17: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/17.jpg)
![Page 18: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/18.jpg)
![Page 19: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/19.jpg)
![Page 20: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/20.jpg)
![Page 21: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/21.jpg)
![Page 22: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/22.jpg)
![Page 23: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/23.jpg)
![Page 24: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/24.jpg)
![Page 25: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/25.jpg)
![Page 26: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/26.jpg)
![Page 27: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/27.jpg)
![Page 28: sites.utoronto.casites.utoronto.ca/acdclab/pubs/PM/23241603.pdf · To date, only CA125, a large mucin-type glycoprotein, is widely used as an ovarian cancer biomarker in the clinical](https://reader035.fdocuments.us/reader035/viewer/2022071102/5fdb99100fb4750da623b45d/html5/thumbnails/28.jpg)